Filtros

Buscador
Año
Martin-Broto J, Martinez-Garcia J, Moura DS, Redondo A, Gutierrez A, Lopez-Pousa A, Martinez-Trufero J, Sevilla I, Diaz-Beveridge R, Solis-Hernandez MP, Carnero A, Perez M, Marcilla D, Garcia-Foncillas J, Romero P, Fernandez-Jara J, Lopez-Lopez D, Arribas I, Hindi N. Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/ CDKN2A. Signal Transduct Target Ther. 2023 Oct 25;8(1):405. doi: 10.1038/s41392-023-01661-8. PubMed PMID: 37875500; PubMed Central PMCID: PMC10598203.
AÑO: 2023; IF: 40.8
Vergote I, Perez-Fidalgo JA, Hamilton EP, Valabrega G, Van Gorp T, Sehouli J, Cibula D, Levy T, Welch S, Richardson DL, Guerra EM, Scambia G, Henry S, Wimberger P, Miller DS, Klat J, Martinez-Garcia J, Raspagliesi F, Pothuri B, Romero I, Bergamini A, Slomovitz B, Schochter F, Hogdall E, Farinas-Madrid L, Monk BJ, Michel D, Kauffman MG, Shacham S, Mirza MR, Makker V; ENGOT-EN5/GOG-3055/SIENDO Investigators. Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer. J Clin Oncol. 2023 Dec 10;41(35):5400-5410. doi: 10.1200/JCO.22.02906. Epub 2023 Sep 5. PubMed PMID: 37669480.
AÑO: 2023; IF: 42.1
Antonio CCP, Alida GG, Elena GG, Rocio GS, Jeronimo MG, Luis ARJ, Anibal ND, Francisco BV, Jesus GRA, Pablo RR, Jose GM. Cytoreductive Surgery With or Without HIPEC After Neoadjuvant Chemotherapy in Ovarian Cancer: A Phase 3 Clinical Trial. Ann Surg Oncol. 2022 Apr;29(4):2617-2625. doi: 10.1245/s10434-021-11087-7. Epub 2021 Nov 23. PubMed PMID: 34812982.
AÑO: 2022; IF: 3.7
Cascales-Campos PA, Gonzalez-Gil A, Fernandez-Luna E, Gil-Gomez E, Alconchel-Gago F, Romera-Garcia A, Martinez-Garcia J, Nieto-Diaz A, Barcelo-Valcarcel F, Gil-Martinez J. Urinary and fecal incontinence in patients with advanced ovarian cancer treated with CRS + HIPEC. Surg Oncol. 2021 Mar;36:115-119. doi: 10.1016/j.suronc.2020.12.001. Epub 2020 Dec 11. PubMed PMID: 33341606.
AÑO: 2021; IF: 2.388
Gomez-Ruiz AJ, Gonzalez-Gil A, Gil J, Alconchel F, Navarro-Barrios A, Gil-Gomez E, Martinez J, Nieto A, Garcia-Palenciano C, Cascales-Campos PA. Acute renal disease in patients with ovarian peritoneal carcinomatosis treated with cytoreduction and HIPEC: the influence of surgery and the cytostatic agent used. Langenbecks Arch Surg. 2021 Nov;406(7):2449-2456. doi: 10.1007/s00423-021-02279-6. Epub 2021 Jul 20. PubMed PMID: 34283300.
AÑO: 2021; IF: 2.895